SCHEMBL5079025

SCHEMBL5079025

Nc1nc(-c2ccc3ccc(-c4ccccc4)nc3c2)cn2c(C3CC(O)CN3)ncc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.41
INSR P06213 5/20 0.41
MAPK3 P27361 2/20 0.41
MAPK1 P28482 2/20 0.41
KDR P35968 2/20 0.41
RIPK2 O43353 1/20 0.41
ROCK2 O75116 1/20 0.41
LATS1 O95835 1/20 0.41
LCK P06239 1/20 0.41
LYN P07948 1/20 0.41
RET P07949 1/20 0.41
ABCB1 P08183 1/20 0.41
MET P08581 1/20 0.41
FGFR1 P11362 1/20 0.41
INSRR P14616 1/20 0.41
FECH P22830 1/20 0.41
MARK3 P27448 1/20 0.41
FLT4 P35916 1/20 0.41
MAP2K2 P36507 1/20 0.41
FLT3 P36888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18952119 0.80 IGF1R (0.61) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL1566436 0.77 IGF1R (0.49) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL4391984 0.77 IGF1R (0.39) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL400132 0.77 IGF1R (0.68) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL4073244 0.75 IGF1R (0.51) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL398892 0.74 IGF1R (0.45) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL5083797 0.74 IGF1R (0.38) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL5080364 0.74 IGF1R (0.36) IGF1RINSRMAPK3MAPK1KDR
SCHEMBL5081320 0.74 TNK2 (0.44) IGF1RINSRKDRCYP3A4EGFR
SCHEMBL5082616 0.74 IGF1R (0.36) IGF1RINSRMAPK3MAPK1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP disclosed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO disclosed